Remedies for ischemia


Ontology type: sgo:Patent     


Patent Info

DATE

N/A

AUTHORS

Wolfgang M. Franz , Hans Theiss , Marc-Michael Zaruba , Stefan Brunner

ABSTRACT

The present invention relates to uses and methods of parathyroid hormone (PTH), preferably PTH (1-34), and/or parathyroid hormone-related peptide (PTHrP), preferably PTHrP (1-34), for recruiting stem cells into tissue suffering from ischemia, wherein said stem cells are preferably capable of repairing and/or regenerating said tissue suffering from ischemia. Also provided is the use of a combination of G-CSF or a G-CSF fragment and a DPP IV inhibitor/antagonist in the medical intervention of an ischemic disorder. Accordingly, the uses and methods of the present invention are preferably suitable for the prevention and/or treatment of ischemia. Moreover, the present invention relates to a composition comprising parathyroid hormone (PTH), preferably PTH (1-34), and/or parathyroid hormone-related peptide (PTHrP), preferably PTHrP (1-34), and/or G-CSF or a G-CSF fragment for use as a pharmaceutical composition. In a particular aspect of the invention, a DPP IV antagonist is applied in the uses, methods and/or compositions of the present invention. The DPP IV antagonist/inhibitor is preferably used in combination with G-CSF or a G-CSF fragment. Also the use of PTH alone or PTHrP alone or in combination with a DPP IV antagonist as well as the one of a combination of G-CSF or a G-CSF fragment and a DPP IV inhibitor/antagonist in the herein disclosed medical and pharmaceutical uses and methods is part of this invention. More... »

Related SciGraph Publications

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/3053", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "name": "Wolfgang M. Franz", 
        "type": "Person"
      }, 
      {
        "name": "Hans Theiss", 
        "type": "Person"
      }, 
      {
        "name": "Marc-Michael Zaruba", 
        "type": "Person"
      }, 
      {
        "name": "Stefan Brunner", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/nature02040", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003509222", 
          "https://doi.org/10.1038/nature02040"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jacc.2006.07.044", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017209192"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "description": "

The present invention relates to uses and methods of parathyroid hormone (PTH), preferably PTH (1-34), and/or parathyroid hormone-related peptide (PTHrP), preferably PTHrP (1-34), for recruiting stem cells into tissue suffering from ischemia, wherein said stem cells are preferably capable of repairing and/or regenerating said tissue suffering from ischemia. Also provided is the use of a combination of G-CSF or a G-CSF fragment and a DPP IV inhibitor/antagonist in the medical intervention of an ischemic disorder. Accordingly, the uses and methods of the present invention are preferably suitable for the prevention and/or treatment of ischemia. Moreover, the present invention relates to a composition comprising parathyroid hormone (PTH), preferably PTH (1-34), and/or parathyroid hormone-related peptide (PTHrP), preferably PTHrP (1-34), and/or G-CSF or a G-CSF fragment for use as a pharmaceutical composition. In a particular aspect of the invention, a DPP IV antagonist is applied in the uses, methods and/or compositions of the present invention. The DPP IV antagonist/inhibitor is preferably used in combination with G-CSF or a G-CSF fragment. Also the use of PTH alone or PTHrP alone or in combination with a DPP IV antagonist as well as the one of a combination of G-CSF or a G-CSF fragment and a DPP IV inhibitor/antagonist in the herein disclosed medical and pharmaceutical uses and methods is part of this invention.

", "id": "sg:patent.US-8455435-B2", "keywords": [ "remedy", "ischemia", "invention", "method", "parathyroid hormone", "Parathyroid Hormone-Related Protein", "parathyroid hormonerP", "stem cell", "tissue", "wherein", "regenerating", "CSF", "fragment", "DPP IV", "medical intervention", "disorder", "prevention", "composition", "pharmaceutical", "particular aspect" ], "name": "Remedies for ischemia", "recipient": [ { "id": "https://www.grid.ac/institutes/grid.5252.0", "type": "Organization" } ], "sameAs": [ "https://app.dimensions.ai/details/patent/US-8455435-B2" ], "sdDataset": "patents", "sdDatePublished": "2019-03-07T15:33", "sdLicense": "https://scigraph.springernature.com/explorer/license/", "sdPublisher": { "name": "Springer Nature - SN SciGraph project", "type": "Organization" }, "sdSource": "s3://com.uberresearch.data.dev.patents-pipeline/full_run_10/sn-export/5eb3e5a348d7f117b22cc85fb0b02730/0000100128-0000348334/json_export_2f12e043.jsonl", "type": "Patent" } ]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/patent.US-8455435-B2'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/patent.US-8455435-B2'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/patent.US-8455435-B2'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/patent.US-8455435-B2'


 

This table displays all metadata directly associated to this object as RDF triples.

60 TRIPLES      14 PREDICATES      35 URIs      27 LITERALS      2 BLANK NODES

Subject Predicate Object
1 sg:patent.US-8455435-B2 schema:about anzsrc-for:3053
2 schema:author N3a17d9c262134be9a175f6b3370b428e
3 schema:citation sg:pub.10.1038/nature02040
4 https://doi.org/10.1016/j.jacc.2006.07.044
5 schema:description <p num="p-0001">The present invention relates to uses and methods of parathyroid hormone (PTH), preferably PTH (1-34), and/or parathyroid hormone-related peptide (PTHrP), preferably PTHrP (1-34), for recruiting stem cells into tissue suffering from ischemia, wherein said stem cells are preferably capable of repairing and/or regenerating said tissue suffering from ischemia. Also provided is the use of a combination of G-CSF or a G-CSF fragment and a DPP IV inhibitor/antagonist in the medical intervention of an ischemic disorder. Accordingly, the uses and methods of the present invention are preferably suitable for the prevention and/or treatment of ischemia. Moreover, the present invention relates to a composition comprising parathyroid hormone (PTH), preferably PTH (1-34), and/or parathyroid hormone-related peptide (PTHrP), preferably PTHrP (1-34), and/or G-CSF or a G-CSF fragment for use as a pharmaceutical composition. In a particular aspect of the invention, a DPP IV antagonist is applied in the uses, methods and/or compositions of the present invention. The DPP IV antagonist/inhibitor is preferably used in combination with G-CSF or a G-CSF fragment. Also the use of PTH alone or PTHrP alone or in combination with a DPP IV antagonist as well as the one of a combination of G-CSF or a G-CSF fragment and a DPP IV inhibitor/antagonist in the herein disclosed medical and pharmaceutical uses and methods is part of this invention.</p>
6 schema:keywords CSF
7 DPP IV
8 Parathyroid Hormone-Related Protein
9 composition
10 disorder
11 fragment
12 invention
13 ischemia
14 medical intervention
15 method
16 parathyroid hormone
17 parathyroid hormonerP
18 particular aspect
19 pharmaceutical
20 prevention
21 regenerating
22 remedy
23 stem cell
24 tissue
25 wherein
26 schema:name Remedies for ischemia
27 schema:recipient https://www.grid.ac/institutes/grid.5252.0
28 schema:sameAs https://app.dimensions.ai/details/patent/US-8455435-B2
29 schema:sdDatePublished 2019-03-07T15:33
30 schema:sdLicense https://scigraph.springernature.com/explorer/license/
31 schema:sdPublisher Na70b62f619554f989c98f7ea982a6744
32 sgo:license sg:explorer/license/
33 sgo:sdDataset patents
34 rdf:type sgo:Patent
35 N1cb993cbe4934b3d9d9517ef6f2730ff schema:name Marc-Michael Zaruba
36 rdf:type schema:Person
37 N2c84201653f84256a8ee0e9f9843ba56 rdf:first N60a7ab8b98ca4401955827251aefa132
38 rdf:rest Nbf06b32563164ae6ab7fe82e44452121
39 N3a17d9c262134be9a175f6b3370b428e rdf:first N76fcc9ca289f456eac6fa24920f6ae9e
40 rdf:rest N2c84201653f84256a8ee0e9f9843ba56
41 N60a7ab8b98ca4401955827251aefa132 schema:name Hans Theiss
42 rdf:type schema:Person
43 N76fcc9ca289f456eac6fa24920f6ae9e schema:name Wolfgang M. Franz
44 rdf:type schema:Person
45 N875a730be9d04f24a6c7673c825b587d schema:name Stefan Brunner
46 rdf:type schema:Person
47 N9c6a359c6cb447acbaf54a66a67dffe7 rdf:first N875a730be9d04f24a6c7673c825b587d
48 rdf:rest rdf:nil
49 Na70b62f619554f989c98f7ea982a6744 schema:name Springer Nature - SN SciGraph project
50 rdf:type schema:Organization
51 Nbf06b32563164ae6ab7fe82e44452121 rdf:first N1cb993cbe4934b3d9d9517ef6f2730ff
52 rdf:rest N9c6a359c6cb447acbaf54a66a67dffe7
53 anzsrc-for:3053 schema:inDefinedTermSet anzsrc-for:
54 rdf:type schema:DefinedTerm
55 sg:pub.10.1038/nature02040 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003509222
56 https://doi.org/10.1038/nature02040
57 rdf:type schema:CreativeWork
58 https://doi.org/10.1016/j.jacc.2006.07.044 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017209192
59 rdf:type schema:CreativeWork
60 https://www.grid.ac/institutes/grid.5252.0 schema:Organization
 




Preview window. Press ESC to close (or click here)


...